Search by Drug Name or NDC
NDC 70436-0091-06 Montelukast Sodium 5 mg/1 Details
Montelukast Sodium 5 mg/1
Montelukast Sodium is a ORAL TABLET, CHEWABLE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Slate Run Pharmaceuticals, LLC.. The primary component is MONTELUKAST SODIUM.
Product Information
| NDC | 70436-0091 |
|---|---|
| Product ID | 70436-091_ff407f66-1098-2364-e053-6394a90a6fe5 |
| Associated GPIs | 44505050100520 |
| GCN Sequence Number | 037003 |
| GCN Sequence Number Description | montelukast sodium TAB CHEW 5 MG ORAL |
| HIC3 | Z4B |
| HIC3 Description | LEUKOTRIENE RECEPTOR ANTAGONISTS |
| GCN | 94440 |
| HICL Sequence Number | 016911 |
| HICL Sequence Number Description | MONTELUKAST SODIUM |
| Brand/Generic | Generic |
| Proprietary Name | Montelukast Sodium |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Montelukast Sodium |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, CHEWABLE |
| Route | ORAL |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/1 |
| Substance Name | MONTELUKAST SODIUM |
| Labeler Name | Slate Run Pharmaceuticals, LLC. |
| Pharmaceutical Class | Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA205695 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70436-0091-06 (70436009106)
| NDC Package Code | 70436-091-06 |
|---|---|
| Billing NDC | 70436009106 |
| Package | 90 TABLET, CHEWABLE in 1 BOTTLE (70436-091-06) |
| Marketing Start Date | 2018-03-13 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.0769 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | MONTELUKAST SOD 5 MG TAB CHEW |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis